TECX - NASDAQ

TT

Tectonic Therapeutic, Inc.

TECXยทNASDAQ

$29.13

+6.2%
HealthcareBiotechnology

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$549.66M
EPS-4.0500
P/E Ratio-7.19
Earnings Date08/06/2026
TT

Tectonic Therapeutic, Inc. Fair Value Envelope

TECX ยท NASDAQ

Our analysis suggests that TECX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $29.13, this represents a potential HIDDEN relative to our calculated worth for Tectonic Therapeutic, Inc..

HIDDEN
Intrinsic Value
Current Price: $29.13

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value-$370.2M
+ Cash & Equivalents$253.8M
Firm Value-$116.4M
- Debt$1.3M
Equity Value-$117.7M
/ Shares Outstanding18,712,128B
DCF Value-$6
OVERVALUED BY 122%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
-$59.0M
-$58.0M
-$56.9M
-$55.9M
-$54.9M
-$54.0M
-$53.0M
-$52.1M
-$51.1M
-$50.2M
Maintenance CapEx
-$40.9K
-$40.1K
-$39.4K
-$38.7K
-$38.0K
-$37.4K
-$36.7K
-$36.1K
-$35.4K
-$34.8K
Owner Earnings
-$59.1M
-$58.0M
-$57.0M
-$56.0M
-$55.0M
-$54.0M
-$53.0M
-$52.1M
-$51.2M
-$50.3M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
-$54.7M
-$49.7M
-$45.2M
-$41.1M
-$37.4M
-$34.0M
-$31.0M
-$28.2M
-$25.6M
-$23.3M
Terminal Value represents 0.0% of Enterprise Value
Negative Owner Earnings
This company generates negative free cash flow. Consider adjusting maintenance CapEx percentage or check the financial data.

Related Guides

Blog Categories

Continue your TECX research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.